Katarina Stark

561 total citations
12 papers, 421 citations indexed

About

Katarina Stark is a scholar working on Pharmacology, Pharmacology and Biochemistry. According to data from OpenAlex, Katarina Stark has authored 12 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Pharmacology and 6 papers in Biochemistry. Recurrent topics in Katarina Stark's work include Pharmacogenetics and Drug Metabolism (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Katarina Stark is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Katarina Stark collaborates with scholars based in Sweden, United States and Spain. Katarina Stark's co-authors include F. Peter Guengerich, Ernst H. Oliw, Miroslav Dostálek, Hans Törmä, Johan Bylund, Alvin Gomez, Inger Johansson, Robert Burman, Jenny Svärd and María Luisa Bernal and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

Katarina Stark

11 papers receiving 408 citations

Peers

Countries citing papers authored by Katarina Stark

Since Specialization

Citations

This map shows the geographic impact of Katarina Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Stark more than expected).

Fields of papers citing papers by Katarina Stark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Stark. The network helps show where Katarina Stark may publish in the future.

Co-authorship network of co-authors of Katarina Stark

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Stark. A scholar is included among the top collaborators of Katarina Stark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Stark. Katarina Stark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	mRNA Distribution and Heterologous Expression of Orphan Cytochrome P450 20A1 2008 ·Drug Metabolism and Disposition ·Katarina Stark, Zhong‐Liu Wu, Cheryl Bartleson, F. Peter Guengerich	29
2	Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide 2008 ·FEBS Journal ·Katarina Stark, Miroslav Dostálek, F. Peter Guengerich	78
3	Characterization of Orphan Human Cytochromes P450 2007 ·Drug Metabolism Reviews ·Katarina Stark, F. Peter Guengerich	50
4	Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions 2006 ·Prostaglandins & Other Lipid Mediators ·Katarina Stark, Hans Törmä, Ernst H. Oliw	15
5	Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1 2006 ·Biochemical and Biophysical Research Communications ·Maria Karlgren, Alvin Gomez, Katarina Stark, Jenny Svärd, Cristina Rodríguez‐Antona, Ernst H. Oliw, María Luisa Bernal, Santiago Ramón y Cajal, Inger Johansson, Magnus Ingelman‐Sundberg	90
6	Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8 2005 ·Archives of Biochemistry and Biophysics ·Katarina Stark, (unknown), Robert Burman, Ernst H. Oliw	35
7	Expression of CYP4F12 in Gastrointestinal and Urogenital Epithelia* 2004 ·Basic & Clinical Pharmacology & Toxicology ·Katarina Stark, (unknown), Göran Sahlén, Gunnar Ronquist, Ernst H. Oliw	22
8	On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and expression of cyclooxygenase-2, PGH 19-hydroxylase (CYP4F8) and microsomal PGE synthase-1 in seminal vesicles and vas deferens 2004 ·Prostaglandins & Other Lipid Mediators ·Katarina Stark, Johan Bylund, Hans Törmä, Göran Sahlén, Ernst H. Oliw	10
9	Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes 2004 ·Biochemical and Biophysical Research Communications ·(unknown), Katarina Stark, Erik Eliasson, Ernst H. Oliw, Anders Rane	40
10	Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions 2002 ·Archives of Biochemistry and Biophysics ·Katarina Stark, Hans Törmä, Mirela Cristea, Ernst H. Oliw	24
11	Oxidation of prostaglandin H2 and prostaglandin H2 analogues by human cytochromes P450: analysis of ω-side chain hydroxy metabolites and four steroisomers of 5-hydroxyprostaglandin I1 by mass spectrometry11Abbreviations: CYP, cytochrome P450; HHT, (12S)-hydroxy-5Z,8Z,10E-heptadecatrienoic acid; MDA, malondialdehyde; MS/MS, tandem mass spectrometry; PG, prostaglandin; PGI2, prostacyclin; and TX, thromboxane. 2001 ·Biochemical Pharmacology ·Ernst H. Oliw, Katarina Stark, Johan Bylund	26
12	Necrotizing factor in human sera. 1962 ·PubMed ·(unknown), Robert Fried, Katarina Stark	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact